Dr. Thomas Seyfried is an American professor of biology, genetics, and biochemistry at Boston College. He received his PhD from the University of Illinois Urbana-Champaign in 1976 and did his postdoctoral fellowship at the Yale University School of Medicine.
Dr. Seyfried has over 150 peer-reviewed publications, and his research focuses primarily on the mechanisms driving cancer, epilepsy, and neurodegenerative diseases and calorie-restricted ketogenic diets in their prevention and treatment. He is the author of Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer and presently serves on the Nutrition & Metabolism, Neurochemical Research, Journal of Lipid Research, and ASN Neuro editorial boards.
The HRF Team of Daniel Orrego, Dr. Gregory Howard, and Dr. Michelle Howard describe their research and approach to guiding those diagnosed with cancer, including implementing a protocol that starves the cancer and fuels the body.
Daniel Orrego is a Co-Founder of the Hippocrates Research Foundation. Daniel is advancing a platform of patient advocacy, education, and facilitation to ensure that a broader public can access best-in-class health care in partnership with their physician.
Dr. Gregory Howard and Dr. Michelle Howard are co-founders of the Hippocrates Research Foundation, which studies cancer prevention. They used liquid biopsies to diagnose Dr. Michelle Howard’s stage zero melanoma and ovarian cancers and implemented non-toxic metabolic therapies to keep her cancer in check.
Lara Adler is an Environmental Health Educator and Science Communicator who teaches health professionals and individuals with health-based businesses to better understand the role of environmental chemical exposures in causing or contributing to chronic health issues so they can more comprehensively support the clients/patients they serve. Lara is a member of the National Association of Environmental Medicine and the American Holistic Health Association.
Andrew Lacy is the founder and CEO of Prenuvo, a revolutionary new MRI scan that uses AI technology to detect early signs of various cancers and diseases. It also detects visceral fat and various other anatomical and structural components integral to our health so that patients can feel empowered to take control over their health.
Andrew is a product technologist with extensive experience taking transformative digital products from conception to launch in startups and large corporations. He holds an MBA from Stanford University and a Patent and International Law degree from the University of Melbourne. He’s passionate about using technology to help our healthcare system shift from one focused on treating disease to one focused on prevention.
Dr. Joe Zundell received his Ph.D. in cancer biology through the University of the Sciences and The Wistar Institute in Philadelphia, PA. He has over ten years of cancer research experience as a cancer biologist. Much of his published research has focused on finding new therapies for the treatment of many different cancer types based on the epigenetic and metabolic characteristics of cancers. Currently, he is a research scientist at a biotherapeutic company near Philadelphia, examining immunotherapies for cancer treatment.
